FDA 警告 GLP-1 药物存在引发罕见眼病的风险
STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition
FDA 要求制药公司告知患者和医生 GLP-1 药物可能引发的罕见眼病风险,这种疾病称为非动脉性前部缺血性视神经病变(NAION),可能导致视力突然丧失。
FDA 要求制药公司告知患者和医生 GLP-1 药物可能引发的罕见眼病风险,提醒临床应用中的潜在副作用。
Agency requiring pharma companies to inform patients, doctors of ‘eye stroke’ condition
![]()
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.
The Food and Drug Administration on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition and required pharma companies to inform patients and doctors of the risk.
The condition, called non-arteritic anterior ischemic optic neuropathy, or NAION, is sometimes referred to as an “eye stroke” and is caused by insufficient blood flow to the optic nerve. It typically causes sudden vision loss and, in severe cases, can lead to blindness. There are currently no proven treatments for the condition.
GLP-1 drugs such as Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound have exploded in popularity for their potent weight loss effects, but as with any drugs that are given to large populations, side effects can show up in real-world use that weren’t observed in clinical trials.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
National Biotech Reporter
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.
来源:STAT 主站 · statnews.com